The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection

As tumor and epithelial specific cell marker antigens are expressed differently in disseminated tumor cells, the immunomagnetic enrichment from peripheral blood is most robust and reliable when using a combination of specific antibodies compared to single antibodies.